Jazz Pharmaceuticals plc

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP JAZZ

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

2,159

Value ($000)

367

Weight

0.0%

2019 Q4 - 2025 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	367	0.0%	2,159	12/31/2025
2024 Q3	11/14/2024	8,501	0.0%	76,306	9/30/2024
2024 Q2	8/14/2024	4,721	0.0%	44,237	6/30/2024
2023 Q3	11/14/2023	15,416	0.0%	119,101	9/30/2023
2023 Q2	8/14/2023	37,847	0.0%	305,291	6/30/2023
2023 Q1	5/15/2023	79,683	0.1%	544,540	3/31/2023
2022 Q4	2/14/2023	109,050	0.2%	684,517	12/31/2022
2022 Q3	11/14/2022	66,884	0.1%	501,796	9/30/2022
2022 Q2	8/15/2022	746	0.0%	4,780	6/30/2022
2021 Q3	11/12/2021	3,242	0.0%	24,900	9/30/2021
2021 Q2	8/13/2021	42,252	0.1%	237,852	6/30/2021
2021 Q1	5/14/2021	12,462	0.0%	75,815	3/31/2021
2020 Q2	8/12/2020	13,616	0.0%	123,397	6/30/2020
2020 Q1	5/15/2020	15,316	0.0%	153,564	3/31/2020
2019 Q4	2/13/2020	89,755	0.2%	601,252	12/31/2019